Dow Down 1.10% Nasdaq Down 1.82%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
7.32 Down 0.58(7.34%) Feb 8, 4:00PM EST
Prev Close:7.90
Open:7.77
Bid:N/A
Ask:8.72 x 200
1y Target Est:19.75
Beta:1.772
Next Earnings Date:29-Feb-16HALO Earnings announcement
Day's Range:7.10 - 7.80
52wk Range:7.10 - 25.25
Volume:1,920,011
Avg Vol (3m):1,453,590
Market Cap:928.59M
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HALODown 7.34%928.59M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.34
Quarterly EPS Est (Dec-15) :-0.08
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback